Naver Webtoon announced on Jan. 18 that its webtoon and web novel “Seven Fates: Chakho,” which was created through collaboration with the global boy band BTS, recorded 15 million cumulative views within two days of its global release. It is a new record among the company's works.Thanks to the re
Korea’s biotech venture ABL Bio has licensed out its new drug candidate to Sanofi, the world’s sixth-largest pharmaceutical company in France, in a deal worth up to 1.27 trillion won.“We have signed a technology transfer contract with Sanofi for Parkinson’s disease treatment ABL301,” ABL Bio said in
The Verge reported on Jan. 10 that the next Apple Watch is unlikely to support body temperature measurement and blood pressure and glucose measurement.Meanwhile, Samsung Electronics is enhancing the competitiveness of its smartwatches by actively utilizing biosensor features. For example, the Galaxy
EOFlow Co., a provider of wearable drug delivery solutions in Korea, announced on Oct. 27 that the company will establish a joint venture company SINOFLOW Co., Ltd. in China with Changsha Sinocare Co., Ltd. (Sinocare) to enter the large and growing Chinese diabetes market.According to EOFlow, the jo
The authors are analysts of Shinhan Investment Corp. They can be reached at jhwon@shinhan.com and shawn1225@shinhan.com, respectively. -- Ed. Global IVD company growing rapidly amid COVID-19SD Biosensor is a global in vitro diagnostics (IVD) company with a diversified product portfolio (immunodiagno
GC Pharma has succeeded in entering the Chinese hemophilia drug market.The company said on Aug. 14 that it has obtained approval from China's National Medical Products Administration (NMPA) for its hemophilia treatment GreenGene F. This is the first time that a genetically recombined hemophilia
JW Bioscience, a subsidiary of JW Life Science, announced on Aug. 11 that it has acquired a Chinese patent for its sepsis early diagnosis kit, which is based on tryptophanyl-tRNA synthetase (WRS).WRS is a biomarker which was confirmed, in a 2016 paper published in the journal Nature Microbiology, to
The author is an analyst of NH Investment & Securities. He can be reached at pk.park@nhqv.co. -- Ed. Recently, results on transplanting 3D printed artificial livers in animals were published in Advanced Materials, the world’s most prestigious materials science journal. Following the co-development p
A new hurdle has emerged for Hanmi Pharmaceutical in promoting the entry into the 4.5-trillion-won U.S. market of its first bio drug Rolontis. It is a patent infringement suit filed by Sanofi's subsidiary.Analysts say that although the suit is bad news that occurred just before the final approva
Samsung Electronics announced on June 4 that researchers at the Samsung Advanced Institute of Technology (SAIT), Samsung’s R&D hub dedicated to cutting-edge future technologies, published research in the world-renowned journal ‘Science Advances’ about a technology that overcomes the limitations of s
EOFlow, a provider of wearable drug delivery solutions, announced on May 25 that it has received CE Mark from the European Union (EU) for its wearable insulin pump ‘EOPatch,’ controller ‘ADM’ and smartphone app ‘Narsha.’ Narsha is known to be the world's first commercially approved app that can
The U.S. Food and Drug Administration is expected to conduct due diligence on Hanmi Pharmaceutical's plant in Pyeongtaek sometime in May. The FDA will inspect the production facilities for Hanmi’s neutrophilia drug Rolontis. Originally scheduled for October 2020, the due diligence was postponed
Hanmi Pharmaceutical will release Amosartan Q, a drug for hypertension and hyperlipidemia, in Russia.The company announced on April 20 that its partner Sanofi has obtained sales permission for Tristanium from the Russian government. Tristanium is the local name of Amosartan Q. The drug is a compound
EOFlow, a Korean pharmaceutical company that has developed an innovative wearable insulin pump, plans to expand its wearable drug delivery solutions to other non-insulin drugs.The company disclosed this plan during a session at the 2021 spring symposium of the Korean Endocrine Society, which was hel
The authors are analysts of Shinhan Investment Corp. They can be reached at shawn1225@shinhan.com and jhwon@shinhan.com, respectively. – Ed. Domestic leader in wound care, rising presence in trouble carewhich went public in November 2020, is a leading wound dressing manufacturer in Korea. The compan
The COVID-19 pandemic has been fueling people’s interest in boosting immunity against viruses. Masks have become an everyday item and methods to boost and maintain immunity are gaining popularity.In Korea, red ginseng is the most popular health functional food as it boosts immunity. Red ginseng is o
Chong Kun Dang has filed an application to the Korean Ministry of Food and Drug Safety for conditional approval of its COVID-19 treatment under development.The company announced on March 8 that it has submitted an application for conditional approval and Phase III clinical trial of Nafabeltan (compo
GC Pharma announced on March 3 that it will ship the world's first severe Hunter syndrome treatment, Hunterase ICV (intracerebroventricular), to Japan.This product is administered directly to the brain of a patient through a device inserted into his head. Current intravenous injections do not re
Dongkook Pharmaceutical surpassed 500 billion won in sales for the first time in 2020. Both sales and operating profit enjoyed double-digit growth thanks to an increase in exports and the growth of its healthcare business.Dongkook Pharmaceutical announced on Feb. 23 that it racked up 559.1 billion w
As the COVID-19 pandemic has fueled people’s interest in immunity, a growing number of people are buying red ginseng as a gift for Lunar New Year's Day.The reason why red ginseng is popular as a gift during holidays is that it is a health enhancement gift. Red ginseng is a health functional food